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Abstract
Background: Irritable Bowel Syndrome (IBS) is frequently diagnosed in primary care. Its diagnosis
is based on diagnostic criteria but their use is limited in primary care.
We aimed to assess the diagnostic agreement between the older (Manning's and Rome II) and the
new (Rome III) criteria for the diagnosis of IBS in primary care in Greece.
Methods: Medical records of 5 Health Centers in rural Crete, Greece, were reviewed for a four-
year period and patients with the diagnosis of IBS were invited to a structured interview. Kappa
agreement of the Rome III criteria with the criteria of Manning and Rome II was estimated. One
hundred and twenty three patients were eligible for interview and 67 (54.5%) participated. Forty-
six (69%) fulfilled the Manning, 32(48%) the Rome II, and 16(24%) the Rome III criteria. Twenty-
seven (40%) patients were identified as IBS according to the questionnaire for the identification of
functional gastrointestinal diseases (FGIDs). The agreement of Rome III with Manning criteria was
poor (kappa = 0.25). The agreement between the FGIDs questionnaire and the Manning, Rome II
and Rome III criteria was: kappa = 0.30, 0.31 and 0.24 respectively. Moderate agreement was found
between the Rome II and III criteria (kappa = 0.51).
Conclusion: Questionnaires and criteria deriving from expert's consensus meetings or tertiary
hospitals are not easy to apply in rural primary care where symptoms are often underestimated by
patients and complicated questions can be confusing.
Background
Irritable Bowel Syndrome (IBS) is frequently diagnosed in
primary care. [1] During the last decades efforts to provide
reliable diagnostic criteria for IBS have been undertaken,
starting with the criteria of Manning [2] and the consen-
suses of Rome I, II and III. [3,4] Classification criteria such
as Rome II developed through experts consensus may be
less applicable to primary care IBS patients [5] and their
implementation in primary and secondary health care set-
tings does not seem to be widely adopted. [6,7]
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In Greece the subject of functional gastrointestinal disor-
ders in primary health care seems to be neglected.[8,9] A
recent study in rural Crete revealed that primary care phy-
sicians failed to diagnose these disorders.[8] This cross-
sectional study led to the development of a database of
patients with IBS. The advent of the new consensus (Rome
III) on the diagnosis of IBS was an important incentive to
explore to what extent the application of the new stand-
ards alters the diagnosis previously made within the pri-
mary care setting in Crete. This paper seeks to explore
issues of diagnostic suitability and applicability of differ-
ent classification criteria when they are used for IBS
patients in primary care.
Methods
Setting and study population
The medical records of four Primary Health Care (PHC)
centers and one primary surgery were reviewed from
March 1996 till February 2000 with a methodology
explained elsewhere.[8] All the patients with the diagnosis
of IBS or spastic colitis or functional disorders of the large
bowel were pooled together as IBS patients (ICPC 2: D93/
ICD10: K58). The estimated occurrence rate of the IBS
patients in this cross-sectional study was 1.2 per 1000 per-
son-years. [8] This low IBS rate was attributed to the free
access that Greek patients have to public health services
without prior referral from their primary care centre. It
was also uncertain to what extend patients with IBS were
experiencing minor symptoms and thus they did not seek
medical care from their primary care physicians. [8]
Patients with IBS in this Cretan database were mostly
women older than 70 and this fact can explain the high
occurrence rate of IBS in people older than 65 years. How-
ever, both findings from this report need to be verified in
future studies in this region.
All the identified IBS patients were considered eligible for
a structured interview.
Instruments
Each of the eligible patients was personally invited to a
semi-structured interview. All interviews were performed
by the same researcher during scheduled home visits and
were based on a detailed personal and family history
questionnaire. Co-morbidity and medication were docu-
mented both through direct questions during the inter-
view and by patient's personal insurance book. The
Manning criteria for IBS and the Rome II criteria for IBS
and dyspepsia were applied. [2,3]
The questionnaire for the identification of dyspepsia in
the general population (IDGP), which was translated and
validated into Greek [10,11] was applied in order to doc-
ument co-morbidity with dyspepsia and GERD. It consists
of 11 main questions answered by yes or no, on upper gas-
trointestinal symptoms together with frequencies and
consultation behavior, and one open question. The ques-
tionnaire for the identification of functional gastrointesti-
nal disorders (FGIDs) [12] was also used. This
questionnaire based on the Rome I criteria through nine
different sets of questions provides a detailed picture of
patients gastrointestinal problems. Main questions on
symptoms duration from this questionnaire combined
with Rome's II three main diagnostic criteria extended our
comparison towards Rome III criteria retrospectively. All
the diagnostic criteria and the questions used for the
Rome III are shown in Table 1.
Statistical analysis
Comparisons of the characteristics of participants and
non-participants were made using the chi-squared test for
categorical variables and the non-parametric Mann-Whit-
ney test for possible age differences, as age appeared neg-
atively skewed in each group. In the FGIDs questionnaire
age is a criterion for the differential diagnosis of organic
disease against IBS thus no comparison with age was per-
formed for this questionnaire. The chance-corrected
agreement between the Manning and the Rome II criteria
compared with the new Rome III criteria was estimated
using Cohen's kappa [13]. Confidence intervals were cal-
culated using the asymptotic variance, based on the nor-
mal approximation to the distribution of the kappa
statistic [14]. Strength of agreement was interpreted using
the following categories: < 0.20 poor, 0.20–0.40 fair,
0.41–0.60 moderate, 0.61–0.80 good, over 0.80 very
good [14] Possible age and sex differences between the
proportions classified with IBS using the three criteria
(Manning's, Rome II, and Rome III) were assessed using
the Mann-Whitney test and Fisher's exact test respectively.
Confidence intervals for single proportions, and for differ-
ences between proportions, were calculated using the nor-
mal approximation to the binomial distribution. SPSS
version 15 was used for all statistical analyses (SPSS for
Windows, release 15.0.0, and 6/9/2006. Chicago: SPSS
Inc). The significance level was set to 5%.
Ethics
This study was approved by the Ethical Committee of the
University Hospital of Heraklion, Crete, Greece (RN:
7173/2000). All participating patients were informed
about the purposes of the study and gave their consent.
Participation
The original database included 146 patients identified
with the diagnosis of IBS. [8] Ten double entries were
located. For thirteen entries, no date of birth was availa-
ble. These patients were excluded due to the high possibil-
ity of synonymies. Finally, 123 patients were contacted for
interview. Sixty-seven patients participated in the inter-
view (54.5%). A flowchart including reasons for non-par-BMC Research Notes 2008, 1:127 http://www.biomedcentral.com/1756-0500/1/127
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ticipation is shown in Figure 1. The mean interval period
between the original doctor's diagnosis and the interview
was 6.4 (SD: 1.24) years. The characteristics of patients
with IBS according to participation status are presented in
Table 2. Age distribution was not found to differ between
the two groups (Mann-Whitney z = -1.543, p = 0.123).
There was weak evidence of an association between sex
and participation status (X2 = 4.24 on 1 df, p = 0.039),
with more male non-participants than expected (25
observed, 20 expected) and fewer female non-participants
(31 observed, 36 expected).
Old vs new diagnostic criteria
Of the 67 IBS patients that finally participated in the inter-
view, 46 (69%, 95% CI: 58%–80%) fulfilled two or more
of the Manning criteria by the time of interview. Thirty-
two subjects (48%, 95% CI: 36%–60%) fulfilled the
Rome II criteria, all of them also fulfilled the criteria of
Manning. The modified Rome III questions/criteria were
satisfied by 16 subjects (24%, 95% CI: 14%–34%), all of
whom also fulfilled both Rome II and Manning criteria.
Twenty-seven patients (40%, 95% CI: 29%–52%) satis-
fied the conditions for IBS according to the FGIDs ques-
tionnaire.
Poor agreement was found between the Rome III and the
Manning criteria, kappa = 0.25 (95% CI: 0.12 to 0.38).
Only moderate agreement was found between the Rome
II and Rome III criteria, kappa 0.51(95% CI: 0.33 to 0.69).
There was also poor agreement between the FGIDs ques-
tionnaire and the Manning, Rome II and the Rome III cri-
teria with kappa = 0.30 (95% CI: 0.12 to 0.49), kappa = 0.
31 (95% CI: 0.08 to 0.53) and kappa = 0.24 (95% CI: 0.01
to 0.46) respectively. Gender and age were not statistically
Table 1: All diagnostic criteria for IBS and the questions matching Rome III
Manning Criteria
Abdominal pain with 2 or more of the following:
1. Abdominal pain relieved by defecation; and/or
2. Abdominal pain onset associated with more frequent stools; and/or
3. Abdominal pain associated with looser stools; and/or
4. Abdominal distension or bloating; and/or
5. Feeling of incomplete defecation; and/or
6. Mucus in stools (Br Med J 1978)
Rome II Criteria for IBS
At least 12 weeks or more, which need not be consecutive, in the preceding 12 months, of abdominal discomfort or pain that has 2 out of 3 
features:
1. Relieved by defecation
2. Onset associated with a change in frequency of stool
3. Onset associated with a change in form (appearance) of stool
Symptoms that Cumulatively Support the Diagnosis of IBS:
1. Abnormal stool frequency (may be defined as greater than 3 bowel movements per day and less than 3 bowel movements per week);
2. Abnormal stool form (lumpy/hard or loose/watery stool);
3. Abnormal stool passage (straining, urgency, or feeling of incomplete evacuation);
4. Passage of mucus;
5. Bloating or feeling of abdominal distension. (Gut. 1999)
Rome III
Recurrent abdominal pain or discomfort at least 3 days per month in the last 3 months associated with 2 or more of the following:
1. Improvement with defecation
2. Onset associated with a change in frequency of stool
3. Onset associated with a change in form (appearance) of stool
Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis.(Gastroenterology 2006)
Rome III matching questions from the interview
Abdominal discomfort or pain
1. Relieved by defecation
2. Onset associated with a change in frequency of stool
3. Onset associated with a change in form (appearance) of stool
(Rome II)
1. "How many times per week do you experience the symptoms? (1 per week/less frequent/more frequent)". Patients who answered that they 
experienced the symptoms less than one time per week were considered as negative for the Rome III criteria.
2. "For how long have you been experiencing the symptoms? (1 year/2 years/5 years)". When patients answered that they had been experiencing the 
symptoms for less than a year the duration was noted (in months).
(FGIDs questionnaire)BMC Research Notes 2008, 1:127 http://www.biomedcentral.com/1756-0500/1/127
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significant risk factors for the positive diagnosis of IBS
with any of the diagnostic criteria.
Co morbidity
Five (7.5%, 95% CI: 1.2%–13.8%) of the participants
stated that they did not suffer from any gastrointestinal
symptom in the last 12 months prior to the interview.
The investigation for co morbidity with other gastrointes-
tinal disorders revealed 31 patients (46%, 95% CI: 34%–
58%) experiencing GERD like symptoms according to the
IDGP questionnaire. Within this group of patients 24
(77.4%) fulfilled the criteria of Manning, whereas 15
(48.4%) and 8 (25.8%) fulfilled the Rome II and III crite-
ria respectively. Nine of the 67 patients (13%, 95% CI: 5%
to 22%) patients had undergone cholecystectomy or expe-
rienced gall bladder problems in the past. Seven (10.4%,
95% CI: 2.5% to18%) patients had dyspepsia according
to the IDGP questionnaire and one patient had FD
according to Rome II. Four of the patients (6%, 95% CI:
0.3% to12%) had been diagnosed with cancer (1 gastric,
1 ovarian, 2 cervical).
Sixteen patients were suffering from one or more gastroin-
testinal symptom (24%, 95% CI: 14% to 34%) without
fulfilling any of the IBS criteria. Symptoms more fre-
quently than 6 times per year were reported by 59 (88%)
of the participants whereas 3 (0.4%) had symptoms less
frequently.
The main findings of the study
In our study population more patients fulfilled Manning's
criteria, fewer the Rome II and even fewer the Rome III cri-
teria which proved the most restrictive. In previous studies
the criteria of Manning and the Rome III criteria were
found more sensitive in diagnosing IBS patients in pri-
mary care compared to Rome II. [15-17] The complexity
of questions about the duration of symptoms might have
played an important role for the difference between the
Rome II and III criteria. It is also supported that criteria
that are based on the frequency of symptoms have lower
prevalence values compared to criteria based on the pres-
ence of symptoms. [18,19] Our findings indicate that IBS
diagnosis in rural areas of Crete has not been based on
complex criteria. In the same vein, the FGIDs question-
naire revealed fewer patients as having IBS than the Man-
ning and Rome II criteria and showed low agreement
compared with all the criteria. This questionnaire was
expected to be more restrictive in the primary care popu-
lation as there is a strong argument that primary care
patients have different disease characteristics than outpa-
tients. [19,20]
High co-morbidity with GERD like symptoms was noted.
The observed rate in our study (46%) was among the
highest reported according to a review of the international
literature. [21] It is difficult to explain this prominent
overlap and although both conditions are highly preva-
lent, the overlapping symptoms are lately attributed to a
Table 2: Characteristics of the 123 patients diagnosed as having IBS
Overall N 123, (100%) Participants
N 67, (55%)
Non-participants
N 56, (45%)
Significance
p = 0.039
Sex
Male 43 (35%) 18 (27%) 25 (44.5%)
Female 80 (65%) 49 (73%) 31 (55%)
Median age (min-max) 71 (20–97) 70 (28–92) 76 (20–97) p = 0.342
Age groups
25–44 7 (10.4%) 4 (7%)
45–64 25 (37.3%) 14 (25%)
65–79 25 (37.3%) 15 (26.7%)
> 80 10 (14.9%) 22 (39.3%)
Education
None 6 (9%) Not known in most
Primary 50 (74.6%) cases
Secondary 11 (16.4%)BMC Research Notes 2008, 1:127 http://www.biomedcentral.com/1756-0500/1/127
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possible common disease process. [22] Co morbidity with
dyspepsia was relatively low (10.4%) compared with
other studies. [20]
The study findings in the light of other studies
Criteria developed by specialists have been criticized for
low performance in primary care.[6,23,24] Skepticism as
to the degree of relevance of Rome diagnostic criteria for
IBS with everyday clinical primary practice is developing
and authors have suggested that the next consensus meet-
ing on IBS should be interdisciplinary. [15,25] Our results
are in agreement with international literature on the low
application of diagnostic criteria for IBS and especially the
Rome II.[5] The Rome III criteria are considered as less
restrictive and thus closer to primary care reality,[16,17]
but in our study this role was not verified. In the Greek
primary setting the number of visits to the doctor due to
IBS was found low [8] compared to international data. In
another study from Crete, again, IBS patients reported that
they did not visit the PHC centre for their IBS problems
frequently. [26] All data form a puzzle showing that in IBS
patients in rural areas of Crete, both actual and as per-
ceived by individuals, symptoms are rather underesti-
mated. Further research is needed to confirm it.
Limitations of the study
Our study used the database of IBS patients identified in
medical records in a retrospective research. Information as
to what criteria were applied by primary care doctors was
not available. In most cases the diagnosis alone was the
only available data. Also poor demographic data entries
resulted in high numbers of excluded or non-participating
patients limiting in this way the strength of the results. For
the majority of the non participating patients there were
no available data about the presence of gastrointestinal
symptoms. Thus a potential selection bias could be
addressed. It should also be noted that although Cohen's
kappa statistic is an extremely widely used measure of
Flow chart of IBS patients Figure 1
Flow chart of IBS patients.BMC Research Notes 2008, 1:127 http://www.biomedcentral.com/1756-0500/1/127
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agreement at the present time in the biomedical literature,
certain "paradoxes" in its interpretation have been noted
in relation to unbalanced marginal totals, and also its
dependence on the prevalence of the condition [27].
Another limitation was the use of modified questions
matching the Rome III instead of the actual Rome III cri-
teria for a retrospective comparison. A similar approach
was attempted in another study the results of which fol-
lowed the pre existing research on Rome III. [14] Our
study provides a hint on the application of the Rome III in
IBS patients in rural Crete at a time where no other infor-
mation is available.
The 6.4 years interval between the first diagnosis and the
structured interview is another limitation as it could allow
changes and overlaps with other gastrointestinal diseases,
a finding common in IBS patients. [28]This interval did
not allow a direct comparison between the criteria and
doctor's diagnosis, but the retrospective comparison
between criteria at the time of interview was possible.
Implementation to practice and suggestions for future 
research
The low agreement between older and new criteria and
the tendency for greater fulfillment of the criteria of Man-
ning; reveal the necessity for a different approach to the
diagnosis of IBS in primary care in rural areas of Greece.
This approach has been also highlighted in a consensus
development for the diagnosis of IBS in primary care. [18]
Clinical manifestations of IBS and co morbidity with
other gastrointestinal diseases; both in primary care
patient and the general population in rural Greece; should
also be investigated in order to obtain a clear picture of the
syndrome.
Conclusion
In Greek primary care, international diagnostic criteria
display low agreement for the diagnosis of IBS. Amongst
these, the newest criteria display worse results than
expected. Questionnaires and criteria deriving from terti-
ary hospitals or expert's consensus meetings seem to be
applied with difficulty in rural primary care where symp-
toms are underestimated by patients and complicated
questions can be confusing.
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